Mon, Jan 26, 2015, 8:44 AM EST - U.S. Markets open in 46 mins.


% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, Inc. Message Board

  • freetoquestionu freetoquestionu Jul 12, 2013 11:32 AM Flag


    Has another trial getting underway. They want to try the drug in metestatic colerectal cancer. I also looked at LEE011 and they added another trial with that drug. That makes 8 trials. Could novaritis being the one that buys astex out? CEO isn't getting any younger. I believe with the dacogen generic news, CEO may accept an offer.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Thanksfor the update Free. On LEE-011, they have started a trial that is for Asian patients with advanced solid tumors. Not sure if I have seen a trial that targets one particular group. Sure that it has happended. I have not seen it. Interesting thought on Novaritis. As you said, they are up to 8 trials with LEE-011. Looks like Novaritis is throwing everything against the wall and sees what sticks. At the JMP presentation yesterday, Astex highlighted LEE-011 yesterday on its own slide for the first time.


    • The good doctor won't seel below the mid teens and no one will provide a 200% premium. So unless the stock price moves into double digits their will be no sale.

8.4950.0000(0.00%)Oct 10 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.